Nucleic Acid Testing Market

The global nucleic acid testing market was valued at USD 2,478.0 million in 2017 and is projected to reach USD 4,154.8 million by the end of 2025, growing at a CAGR of 6.8% during 2018–2025.

Figure 1: Global Nucleic Acid Testing Market Revenue, 2018–2025 (USD Million)

Source: GMI Research

Major Nucleic Acid Testing Market Drivers

The key factors bolstering the market growth are growing awareness and rising molecular diagnosis, improving diagnosis rate in developing regions, advancement in technology and shift from curative healthcare to preventive healthcare across the globe.

Based on the product type, polymerase chain reaction segment is anticipated to lead the market during 2018–2025

Polymerase chain reaction segment is expected to hold the maximum market share of about 40% during the forecast period due to operational simplicity and high efficiency. On the other hand, ligase chain reaction segment is projected to exhibit the highest growth rate due to a number of factors, including the expansion of sequencing into new applications in the clinical and applied market segments.

Based on end user, research institutes dominate the market due to extensive research and development activities and lack of molecular diagnostic labs in developing countries, such as China, India, Brazil, etc. The end-user segment includes hospitals, pathology laboratories, research institutes and clinics. Research Institutes’ segment is expected to grow at an estimated CAGR of 7.0% rate during the forecast period, owing to, rising demand for whole-genome sequencing as preventive care diagnosis grows rapidly. Also, the significant rise in demand for molecular testing for the cancer diagnosis, infectious disease, forensic and other applications are predicted to aid the market growth in the coming years.

Players, such as Abbot Laboratories, F. Hoffmann-La Roche Ltd. and Becton, Dickinson and Company are investing a lot in the research & development activities. The major companies are focusing on product launches for keeping leadership in the global nucleic acid testing market. For instance, around more than hundreds of products are in clinical pipelines for nucleic acid testing kits across the globe.

Figure 2: Global Nucleic Acid Testing Market Revenue, by Region, 2017

Source: GMI Research

Regional – Segment Analysis

North America held the largest share in the global nucleic acid testing market in 2017 owing to the well-developed healthcare system, high disposable income, and favorable reimbursement policies. However, the fastest growth rate is expected to be exhibited by Asia-Pacific during the forecast period owing to increasing adoption of preventive diagnosis care, surging demand for blood transfusion, and government initiatives to implement nucleic acid testing in the public health services.

Top Market Players

Various notable players operating in the market include, Abbott Laboratories, Agilent Technologies, Danaher Corporation, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen, Merck KGaA, Becton, Dickinson and Company, among others.

Segments covered in the Report:

The global nucleic acid testing market has been segmented on the basis of product type, end use and key geographies. Based on the product type, the market comprises of polymerase chain reaction (PCR), transcription-mediated amplification (TMA), ligase chain reaction (LCR), and whole genome sequencing. The end use areas include hospitals, pathology laboratories, research institutes and clinics.

The research report provides in-depth analysis of the global nucleic acid testing market, based on product type, end use and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers fuelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for nucleic acid testing market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.